Kingsview Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,262
Closed -$260K 1097
2024
Q2
$260K Buy
+13,262
New +$252K 0.01% 889
2021
Q2
Sell
-46,354
Closed -$795K 921
2021
Q1
$795K Sell
46,354
-24,195
-34% -$434K 0.05% 391
2020
Q4
$1.35M Buy
70,549
+5,080
+8% +$106K 0.1% 214
2020
Q3
$1.54M Sell
65,469
-36,908
-36% -$884K 0.14% 164
2020
Q2
$2.49M Buy
102,377
+49,427
+93% +$1.22M 0.25% 101
2020
Q1
$1.36M Sell
52,950
-26,138
-33% -$622K 0.18% 141
2019
Q4
$1.75M Buy
79,088
+4,888
+7% +$113K 0.22% 128
2019
Q3
$1.76M Sell
74,200
-1,030
-1% -$23.9K 0.28% 107
2019
Q2
$1.65M Buy
75,230
+20,651
+38% +$450K 0.28% 103
2019
Q1
$1.18M Sell
54,579
-23,651
-30% -$503K 0.18% 153
2018
Q4
$1.73M Buy
+78,230
New +$1.67M 0.38% 80

Other funds holding BTAL

Kingsview Wealth Management's BTAL Position: Q3 2024 in Review

Kingsview Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024, closing a stake of 13,262 shares — an estimated $260K sold.

Kingsview Wealth Management first reported a position in BTAL in Q4 2018 and held it in 11 quarters. The position peaked at $2.49M in Q2 2020. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.

  • Kingsview Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2024 after selling out during the quarter.
  • Kingsview Wealth Management sold 13,262 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $260K.
  • Kingsview Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and held it in 11 quarters.
  • Kingsview Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $2.49M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.

Based on Kingsview Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.